Cite
HARVARD Citation
Hida, T. et al. (2020). Tumor Volume Analysis as a Predictive Marker for Prolonged Survival in Anaplastic Lymphoma Kinase–rearranged Advanced Non–Small Cell Lung Cancer Patients Treated With Crizotinib. Journal of thoracic imaging. 35 (2), p. . [Online].